iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022
iRhythm Technologies, Inc. (NASDAQ: IRTC) will announce its third quarter 2022 financial results on November 1, 2022, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iRhythm Technologies, Inc. (NASDAQ: IRTC) will announce its third quarter 2022 financial results on November 1, 2022, after market close. A conference call is scheduled for 1:30 p.m. PT (4:30 p.m. ET) to discuss the results. iRhythm specializes in digital healthcare solutions that utilize wearable biosensors and cloud-based analytics to provide actionable insights from heart data. This approach aims to improve patient care by delivering better data and health outcomes.
Positive
- Upcoming Q3 2022 financial results may reveal growth or positive metrics.
- Focus on wearable biosensors and data analytics aligns with market trends in digital health.
Negative
- None.
Details
News Market Reaction – IRTC
The recorded move for IRTC in the trading session of this news was +0.66%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Oct. 20, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1, 2022. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the investors section of the Company’s website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Relations Contact
Stephanie Zhadkevich
(919) 452-5430
stephanie.zhadkevich@irhythmtech.com
iRhythm Media Contact
Morgan Mathis
(310) 528-6306
irhythm@highwirepr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.